Five myths about GLP-1 weight loss, set straight

GLP-1 medicines have become the most talked-about — and most misunderstood — tools in weight management. As clinicians, we spend a lot of time separating headline from evidence. Here are the five myths we hear most.

Myth 1: “It’s the easy way out”

GLP-1 therapy quiets the constant appetite signal that makes change hard, but it pairs with eating well and moving more. In the trials, medication was always combined with lifestyle support. It removes a biological headwind; it does not remove the work.

Myth 2: “Everyone should be on it”

It is prescription-only for good reason. It is not appropriate during pregnancy, or for people with certain thyroid or pancreatic histories, and it has side effects. Eligibility is a clinical decision, not a preference — which is exactly why a doctor, not a shopping cart, decides.

Myth 3: “It just melts muscle”

Any rapid weight loss can cost lean mass if protein and resistance training are neglected — this is true of dieting in general, not GLP-1s specifically. With adequate protein and strength work, the loss skews toward fat, which is the goal. We wrote a whole piece on protecting muscle.

Myth 4: “The weight instantly comes back”

Weight regain after stopping is real and well-documented — appetite returns when the signal does. But it is not instant or total, and it is manageable. Treatment is increasingly understood as ongoing care for a chronic condition, with a planned approach to maintenance rather than an abrupt finish.

Myth 5: “It’s either a scam or a miracle”

Both extremes are wrong. Used under medical supervision in appropriate candidates, GLP-1 medication is a well-characterised class with real benefits and real limits. In large trials, average weight loss has been substantial — but averages hide a wide range, results vary, and no honest clinician promises you a specific number.